Stock Events

Stock Events

Daxor 

$10.55
4
-$0.19-1.77% Thursday 20:00
+$0.10+0.95%Thursday 20:00After hours

Statistics

Day High
10.69
Day Low
10.4
52W High
14.76
52W Low
8.56
Volume
2,846
Avg. Volume
-
Mkt Cap
61.59M
P/E Ratio
6.49
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 18
$0.03
Dec 16
$0.03
Dec 15
$0.04
Dec 14
$0.03
Dec 13
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

27FebExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-130.4%Profit Margin
Unprofitable
2010
2011
2016
2017
2018
2019
380,140Revenue
-495,700Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXR. It's not an investment recommendation.
Dow
2
DOW
CME Group
2
CME

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a range of analytical instruments and services that compete with Daxor's blood volume analysis technology.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its subsidiaries, provides products and services in the field of medical diagnostics, competing with Daxor's diagnostic solutions.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company manufactures and sells medical devices, instrument systems, and reagents, offering products that could be used in similar applications as Daxor's.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostics that compete with Daxor.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the healthcare field, offering a wide range of products and services, including diagnostics and medical devices that could compete with Daxor's offerings.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including surgical equipment and diagnostics tools that could be seen as competitive to Daxor's products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, potentially competing with Daxor's diagnostic technologies.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc designs, manufactures, and sells device-based medical therapies and services, including those that could compete with Daxor's blood volume analysis products.
GE Aerospace
GE
Mkt Cap355.45B
General Electric Company, through its healthcare segment, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing in the broader medical diagnostics and research field alongside Daxor.

About

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Show more...
CEO
Michael Richard Feldschuh
Employees
750
Country
United States
ISIN
US2394671034
WKN
000871275

Listings

F
DE
DX5.F
XNAS
US
DXR
BOATS
BOATS
DXR.BOATS

0 Comments

Share your thoughts

FAQ

What is Daxor stock price today?▼
The current price of DXR is $10.55 USD — it has decreased by -1.77% in the past 24 hours. Watch Daxor stock price performance more closely on the chart.
What is Daxor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Daxor stocks are traded under the ticker DXR.
Is Daxor stock price growing?▼
DXR stock has risen by +3.43% compared to the previous week, the month change is a +0.29% rise, over the last year Daxor has showed a -6.88% decrease.
What is Daxor market cap?▼
Today Daxor has the market capitalization of 61.59M
What is Daxor revenue for the last year?▼
Daxor revenue for the last year amounts to 380,140 USD.
What is Daxor net income for the last year?▼
DXR net income for the last year is -495,700 USD.
Does Daxor pay dividends?▼
Yes, DXR dividends are paid annual. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Daxor have?▼
As of September 04, 2026, the company has 750 employees.
In which sector is Daxor located?▼
Daxor operates in the Health & Wellness sector.
When did Daxor complete a stock split?▼
Daxor has not had any recent stock splits.
Where is Daxor headquartered?▼
Daxor is headquartered in NEW YORK, United States.